| PERIOD ENDING | 31-Jan-09 | 31-Jan-08 | 31-Jan-07 | | Total Revenue | 711,146 | 518,868 | 427,017 | | Cost of Revenue | 510,455 | 379,417 | 311,470 | | | Gross Profit | 200,691 | 139,451 | 115,547 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 164,098 | 101,669 | 83,258 | | Non Recurring | 33,523 |
-
|
-
| | Others | 6,947 | 5,427 | 4,431 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (3,877) | 32,355 | 27,858 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | (3,877) | 32,355 | 27,858 | | Interest Expense | 5,564 | 3,158 | 6,362 | | Income Before Tax | (9,441) | 29,197 | 21,496 | | Income Tax Expense | 4,588 | 11,707 | 8,307 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (14,029) | 17,490 | 13,189 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (14,029) | 17,490 | 13,189 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($14,029) | $17,490 | $13,189 |
|
1.48% Nasdaq 
Income Statement
